| Q40534304 | A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile |
| Q40641394 | Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors |
| Q40486586 | Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts. |
| Q34792522 | Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. |
| Q95826169 | Caffeic Acid phenethyl ester inhibits epithelial-mesenchymal transition of human pancreatic cancer cells |
| Q47442506 | Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients |
| Q39907624 | DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC). |
| Q39424192 | DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death. |
| Q89909673 | Development and validation of a UPLC-MS/MS assay for the determination of gemcitabine and its L-carnitine ester derivative in rat plasma and its application in oral pharmacokinetics |
| Q39343347 | Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma |
| Q46875711 | Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival |
| Q40377491 | Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion. |
| Q36210934 | Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models. |
| Q33367641 | Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree |
| Q39222400 | Fixed-dose-rate administration of gemcitabine in cancer-bearing cats: A pilot study |
| Q40391830 | Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells. |
| Q37211966 | Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy |
| Q35197256 | Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes. |
| Q37016687 | Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 "STARD Compliant". |
| Q52646480 | Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations. |
| Q34768930 | Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice |
| Q26996794 | Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis |
| Q33217483 | LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. |
| Q33336057 | Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. |
| Q38903188 | Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. |
| Q93090259 | Meta‑analysis of current chemotherapy regimens in advanced pancreatic cancer to prolong survival and reduce treatment‑associated toxicities |
| Q34234101 | Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients. |
| Q35173833 | New chemotherapy agents in veterinary medicine. |
| Q39039123 | Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer |
| Q33720198 | Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice. |
| Q34589774 | Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model. |
| Q39693708 | Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells. |
| Q39989439 | Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells |
| Q36801789 | The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials |